| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| 23andMe Holding Co. | Head of Therapeutics Discovery | Class A Common Stock | 573,069 | $203,726 | $0.3555 | 20 Aug 2024 | Direct |
| 23andMe Holding Co. | Head of Therapeutics Discovery | Stock Option (Right to Buy) | 166,394 | 15 Sep 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ME | 23andMe Holding Co. | 20 Aug 2024 | 1 | -$20,393 | 4 | Head of Therapeutics Discovery | 21 Aug 2024, 17:29 |
| ME | 23andMe Holding Co. | 20 May 2024 | 1 | -$8,804 | 4 | Head of Therapeutics Discovery | 21 May 2024, 16:06 |
| ME | 23andMe Holding Co. | 20 Feb 2024 | 1 | -$13,244 | 4 | Head of Therapeutics Discovery | 21 Feb 2024, 16:36 |
| ME | 23andMe Holding Co. | 20 Nov 2023 | 1 | -$5,182 | 4 | Head of Therapeutics Discovery | 21 Nov 2023, 16:41 |
| ME | 23andMe Holding Co. | 15 Sep 2023 | 3 | $0 | 4 | Head of Therapeutics Discovery | 19 Sep 2023, 17:11 |
| ME | 23andMe Holding Co. | 05 Sep 2023 | 1 | -$2,741 | 4 | Head of Therapeutics Discovery | 06 Sep 2023, 18:01 |
| ME | 23andMe Holding Co. | 20 Aug 2023 | 1 | -$9,331 | 4 | Head of Therapeutics Discovery | 22 Aug 2023, 17:22 |
| ME | 23andMe Holding Co. | 08 Aug 2023 | 0 | $0 | 3 | Head of Therapeutics Discovery | 11 Aug 2023, 17:41 |